Prevention and repair of circulatory shock and cerebral ischemia/injury by various agents in experimental heatstroke

Medicine & Life Sciences

• Heat Stroke 100%
• Brain Ischemia 67%
• Shock 60%
• Wounds and Injuries 33%
• platonin 20%
• Inflammation 17%
• Rodentia 16%
• HSP72 Heat-Shock Proteins 14%
• Hypertonic Solutions 14%
• Endothelin Receptor Antagonists 13%
• Excitatory Amino Acid Antagonists 12%
• Free Radical Scavengers 12%
• Hyperventilation 11%
• Narcotic Antagonists 11%
• Interleukin-1 Receptors 11%
• Human Serum Albumin 11%
• Multiple Organ Failure 11%
• mu Opioid Receptor 11%
• Starch 11%
• Jugular Veins 10%
• Protein C 10%
• Heat-Shock Response 10%
• Liver Failure 10%
• Pulmonary Edema 10%
• Nitric Oxide Synthase Type II 10%
• Acidosis 10%
• Fetal Blood 9%
• Recombinant Proteins 9%
• Brain 9%
• Hypotension 9%
• Saline Solution 9%
• Arginine 8%
• Glucocorticoids 8%
• Cold Temperature 8%
• Renal Insufficiency 8%
• MEDLINE 8%
• Therapeutic Uses 8%
• Estrogens 8%
• Blood Cells 8%
• Animal Models 7%
• Oxygen 6%
• Survival 5%
• Therapeutics 1%

Chemical Compounds

• Cooling 60%
• Mu-Opioid Receptor Antagonist 51%
• Agent Interacting With Transmitter, Hormone or Drug Receptor 50%
• Interleukin 1 Receptor Blocking Agent 42%
• Glutamate Receptor Antagonist 39%
• Hypertonic Solution 37%
• Nitric Oxide Synthase Inhibitor 34%
• Heat 33%
• Protein C 31%
• Glucocorticoid 29%
• L-Arginine 28%
• Cord 28%
• Radical Scavenger 25%
• Estrogen 24%
• Metabolic 18%
• Free Radical 18%
• Dioxygen 11%
• Protein 9%